Let's talk with Scott Zary, healthc care director, S&P global ratings. I'll start with is the demand growing, slowing, or about the same for all of these drugs that they are obesity drugs, but people are using them just to look lose weight and feel better. Um, tell me about the demand cycle.Uh, thank you for having me on. I I think every time I look at the forecast for this company, the demand uh for Lily, that is the demand continues to grow for uh GLP1s across the board. So I think um when you look at it, ...